Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease as well as critical care and surgical monitoring. We thrive on discovery and expanding the boundaries of medical technology serving patients in 100+ countries with the help of our employees ... Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease as well as critical care and surgical monitoring. We thrive on discovery and expanding the boundaries of medical technology serving patients in 100+ countries with the help of our employees in areas including Clinical Affairs Quality Engineering Research & Development Regulatory Affairs Sales & Marketing corporate functions and more. Our roots date back to 1958 when Miles Lowell Edwards a retired engineer with a background in hydraulics and fuel pump operations set out to build the first artificial heart. Edwards believed the heart could be mechanized and was encouraged by Dr. Albert Starr to focus on developing an artificial heart valve. After just two years the first Starr-Edwards mitral valve was developed and successfully placed in a patient. This innovation spawned Edwards Laboratories. 더 보기
Edwards Lifesciences (NYSE: EW) today announced results from the EARLY TAVR Trial, the first randomized, controlled trial designed to study the best strategy for treating asymptomatic severe...
The Gross Law Firm Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire NEW YORK, Oct. 28, 2024 NEW YORK, Oct. 28, 2024...
Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Sept. 30, 2024. Highlights and Outlook Q3 sales from continuing operations grew 9%; constant currency1...
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2024 after the market closes on Thursday, October 24, 2024, and will host a conference...
The Gross Law Firm Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire NEW YORK, Oct. 17, 2024 NEW YORK, Oct. 17, 2024...
ONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM PR Newswire NAPERVILLE, Ill., Sept. 28, 2024 NAPERVILLE, Ill., Sept. 28, 2024 /PRNewswire/...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.93 | 1.3306624696 | 69.89 | 72.15 | 66.93 | 6499491 | 69.53412991 | CS |
4 | 4.74 | 7.17312348668 | 66.08 | 72.15 | 64.005 | 5655379 | 68.01621531 | CS |
12 | 10.11 | 16.6529402075 | 60.71 | 72.15 | 60.34 | 6316695 | 67.42127713 | CS |
26 | -15.61 | -18.0608584982 | 86.43 | 95.25 | 58.93 | 5072015 | 71.48587377 | CS |
52 | 8.76 | 14.1153722204 | 62.06 | 96.12 | 58.93 | 4606596 | 75.00678422 | CS |
156 | -44.95 | -38.8269845383 | 115.77 | 131.73 | 58.93 | 3700937 | 83.04294588 | CS |
260 | -164.48 | -69.9022524437 | 235.3 | 248.5 | 58.93 | 3094422 | 91.72321638 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관